Health and Fitness Health and Fitness
Tue, September 14, 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals participa en el Simposio Roche Colorado Corporation Peptide 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Aetna Wins Contract for Illinois Managed Medicaid Pilot Program
[ Tue, Sep 14th 2010 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Inves .. Fiduciary Duties by the Officers and Directors of
[ Tue, Sep 14th 2010 ] - Market Wire
El tratamiento VIH de nico comprimido "Quad" de G .. in viral durante 48 semanas en estudio de fase II
[ Tue, Sep 14th 2010 ] - Market Wire
Genmab and Seattle Genetics Enter into Antibody-Drug Conjugate Research Collaboration
[ Tue, Sep 14th 2010 ] - Market Wire
Alexion to Present at the UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Alkermes Announces Posting of Briefing Documents .. ttee Meeting for VIVITROL® for Opioid Dependence
[ Tue, Sep 14th 2010 ] - Market Wire
Guided Therapeutics Completes $3 Million Financing
[ Tue, Sep 14th 2010 ] - Market Wire
Somaxon Pharmaceuticals to Present at the UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Unigene CEO Presents New Strategy and Corporate R .. odman & Renshaw 12th Annual Healthcare Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Derma Sciences to Complete Enrollment in DSC127 Phase 2 Wound Healing Trial This Month
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals interverr al Roche Colorado Corporation Peptide Symposium 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Vortrag von Synergy Pharmaceuticals auf dem Roche Colorado Corporation Peptide Symposium 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals effectuera une pr©sentat .. 10 de Roche Colorado Corporation sur les peptides
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals aanwezig op Roche Colorado Corporation Peptide Symposium 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals to Present at Roche Colorado Corporation Peptide Symposium 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Zalicus To Present at the Rodman & Renshaw Annual Global Investment Conference NYC
[ Tue, Sep 14th 2010 ] - Market Wire
CENTRIC HEALTH APPOINTS DR. PAUL GAMBLE TO BOARD OF DIRECTORS
[ Tue, Sep 14th 2010 ] - Market Wire
Inspire Announces Webcasts of Presentations at th .. nference and the JMP Securities Healthcare Confer
[ Tue, Sep 14th 2010 ] - Market Wire
AngioDynamics Strengthens Executive Team with Key Appointments
Mon, September 13, 2010
[ Mon, Sep 13th 2010 ] - Market Wire
aQuada HIV-kuur in ©©n tablet van Gilead handha .. suppressie gedurende 48 weken in fase-2 onderzoek
[ Mon, Sep 13th 2010 ] - Market Wire
Ironwood Pharmaceuticals Announces Conference Cal .. iscuss Positive Linaclotide Phase 3 IBS-C Results
[ Mon, Sep 13th 2010 ] - Market Wire
Ironwood and Forest Announce Positive Linaclotide .. n Patients with Irritable Bowel Syndrome with Con
[ Mon, Sep 13th 2010 ] - Market Wire
Aetna Reminds Members Affected by the San Bruno Fire Where to Call for Help
[ Mon, Sep 13th 2010 ] - Market Wire
MEDNAX to Present at Stifel Nicolaus 2010 Healthcare Conference
[ Mon, Sep 13th 2010 ] - Market Wire
Benjamin A. Breier Named to Modern Healthcarea?s aUp & Comersa List
[ Mon, Sep 13th 2010 ] - Market Wire
Almirall and Ironwood Announce Positive Results f .. clotide in Patients with Irritable Bowel Syndrome
[ Mon, Sep 13th 2010 ] - Market Wire
WellCare to Participate in Stifel Nicolaus 2010 Healthcare Conference
[ Mon, Sep 13th 2010 ] - Market Wire
AGA Medical to Present at the UBS Global Life Sciences Conference
[ Mon, Sep 13th 2010 ] - Market Wire
Gilead Sciences to Present at the UBS Global Life Sciences Conference on Monday, September 20

Gilead Sciences to Present at the UBS Global Life Sciences Conference on Monday, September 20


Published on 2010-09-13 13:35:30 - Market Wire
  Print publication without navigation


FOSTER CITY, Calif.--([ BUSINESS WIRE ])--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its corporate presentation will be webcast from the UBS Global Life Sciences Conference in New York.

John C. Martin, PhD, Gileada™s Chairman and Chief Executive Officer, will provide an overview of the company on Monday, September 20 at 1:00 p.m. Eastern Daylight Time.

To access the live webcast via the internet log on to [ www.gilead.com ]. Please connect to the companya™s website at least 15 minutes prior to the live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit [ www.gilead.com ] or
call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Contributing Sources